Controversy remains surrounding the use of the PSA test to screen for prostate cancer. This is due to the belief that the PSA test may lead to over-diagnosis and over-treatment in men with low-grade, less aggressive forms of the disease. Clinicians have been long awaiting a new approach to screen for prostate cancer because the current PSA test is simply not accurate enough.